At Waverly Capital, our passion lies in supporting early stage ventures and helping to transform them into thriving businesses. Driven by the finance and management expertise of our Founder Gilad Hayeem, we use our experience as disrupters of conventional approaches to help turn ideas into reality. Our portfolio covers private investments in multiple sectors, including healthcare and biotechnology, financial services, and consumer goods.
Solid Biosciences is a life science company focused on solving Duchenne muscular dystrophy. It was co-founded by Ilan Ganot, Andrey Zarur & Gilad Hayeem in 2013 and Gilad served as President of the company and a member of the Board of Directors from 2013-2018. The company IPOed onto Nasdaq in January 2018 and is currently conducting clinical trials to bring to market a gene-therapy treatment for the disease.
Gilad Hayeem co-founded Marble Bar Asset Management, a long/short actively traded hedge fund, with Hilton Nathanson in 2002. As CEO of the business from inception to sale, Gilad was primarily responsible for developing the business, its asset base and products and oversaw the growth of assets under management to $6bn. MBAM sold strategic stakes to Lehman Brothers from 2002, before a full trade sale to EFG Capital International in 2008.
Co-founded by Gilad Hayeem and Anthony Steinberg in 2010, EMES was established as a fund of hedge funds. Today, it invests and provides capital in various formats and structures to hedge funds globally. Gilad is a partner in the business, which has offices in London, New York and Hong Kong.
Gilad is an entrepreneur with a background in business and asset management. Prior to establishing Waverly Group, he was Managing Partner and CEO of Marble Bar Asset Management, a UK-based investment fund he co-founded in 2002 and sold in 2008. He is also former President of Solid Biosciences, a business he co-founded in 2013 and which listed on Nasdaq in 2018. Gilad received his MBA from City University, London, and holds international history and politics degrees from the University of Leeds, England.